1 01/10/2022 30/09/2023 2023-09-30 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2022-10-01 Sage Accounts Production 23.0 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 04156771 2022-10-01 2023-09-30 04156771 2023-09-30 04156771 2022-09-30 04156771 2021-10-01 2022-09-30 04156771 2022-09-30 04156771 2021-09-30 04156771 bus:RegisteredOffice 2022-10-01 2023-09-30 04156771 bus:Director1 2022-10-01 2023-09-30 04156771 core:WithinOneYear 2023-09-30 04156771 core:WithinOneYear 2022-09-30 04156771 core:RetainedEarningsAccumulatedLosses 2021-10-01 2022-09-30 04156771 core:RetainedEarningsAccumulatedLosses 2022-10-01 2023-09-30 04156771 core:ShareCapital 2023-09-30 04156771 core:ShareCapital 2022-09-30 04156771 core:RetainedEarningsAccumulatedLosses 2023-09-30 04156771 core:RetainedEarningsAccumulatedLosses 2022-09-30 04156771 core:ShareCapital 2021-09-30 04156771 core:RetainedEarningsAccumulatedLosses 2021-09-30 04156771 core:PreviouslyStatedAmount core:ShareCapital 2023-09-30 04156771 bus:Director1 2022-09-30 04156771 bus:Director1 2023-09-30 04156771 bus:Director1 2021-09-30 04156771 bus:Director1 2022-09-30 04156771 bus:SmallEntities 2022-10-01 2023-09-30 04156771 bus:AuditExempt-NoAccountantsReport 2022-10-01 2023-09-30 04156771 bus:SmallCompaniesRegimeForAccounts 2022-10-01 2023-09-30 04156771 bus:PrivateLimitedCompanyLtd 2022-10-01 2023-09-30 04156771 bus:FullAccounts 2022-10-01 2023-09-30
Company registration number: 04156771
Link Medical Limited
Unaudited filleted financial statements
30 September 2023
Link Medical Limited
Contents
Directors and other information
Statement of financial position
Statement of changes in equity
Notes to the financial statements
Link Medical Limited
Directors and other information
Director R W Kenny
Company number 04156771
Registered office Little London Road
Silchester
Berkshire
RG7 2PP
Business address 24 Knights Way
Camberley
Surrey
GU15 1EQ
Link Medical Limited
Statement of financial position
30 September 2023
2023 2022
Note £ £ £ £
Current assets
Debtors 5 13,042 14,215
Cash at bank and in hand 39,446 507,519
_______ _______
52,488 521,734
Creditors: amounts falling due
within one year 6 ( 74,728) ( 551,760)
_______ _______
Net current liabilities ( 22,240) ( 30,026)
_______ _______
Total assets less current liabilities ( 22,240) ( 30,026)
_______ _______
Net liabilities ( 22,240) ( 30,026)
_______ _______
Capital and reserves
Called up share capital 195 195
Profit and loss account ( 22,435) ( 30,221)
_______ _______
Shareholders deficit ( 22,240) ( 30,026)
_______ _______
For the year ending 30 September 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 21 March 2024 , and are signed on behalf of the board by:
R W Kenny
Director
Company registration number: 04156771
Link Medical Limited
Statement of changes in equity
Year ended 30 September 2023
Called up share capital Profit and loss account Total
£ £ £
At 1 April 2022 195 9,608 9,803
Profit/(loss) for the year ( 9,904) ( 9,904)
_______ _______ _______
Total comprehensive income for the year - ( 9,904) ( 9,904)
Dividends paid and payable ( 29,925) ( 29,925)
_______ _______ _______
Total investments by and distributions to owners - ( 29,925) ( 29,925)
_______ _______ _______
At 30 September 2022 and 1 October 2022 195 ( 30,221) ( 30,026)
Profit/(loss) for the year 7,786 7,786
_______ _______ _______
Total comprehensive income for the year - 7,786 7,786
_______ _______ _______
At 30 September 2023 195 ( 22,435) ( 22,240)
_______ _______ _______
Link Medical Limited
Notes to the financial statements
Year ended 30 September 2023
1. General information
The company is a private company limited by shares, registered in England & Wales. The address of the registered office is Brookfields, Little London Road, Silchester, Berkshire, RG7 2PP.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
The company is reliant on the continuing financial support of its creditors and while there are no reasons to doubt that this support will continue, inherently there can be no certainty in relation to these matters. On this basis, and having regard to the company's anticipated future revenues and costs including repayment of debt where appropriate, together with the expected availability of working capital, the director considers it appropriate to prepare the financial statements on the going concern basis. The financial statements do not include any adjustments that would result from an inability to meet obligations as they fall due.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.Current or deferred taxation assets and liabilities are not discounted.Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
Financial instruments
Basic financial instruments with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in administrative expenses. Loans and borrowings are initially recognised at the transaction price includingtransaction costs.
Defined contribution plans
The company operates a defined contribution pension scheme. Contributions payable to the company's pensionscheme are charged to profit or loss in the period to which they relate.
4. Staff costs
The average number of persons employed by the company during the year amounted to 1 (2022: 3 ).
The aggregate payroll costs incurred during the year were:
2023 2022
£ £
Wages and salaries 22,758 109,572
Social security costs 1,418 4,210
Other pension costs - 25,166
_______ _______
24,176 138,948
_______ _______
5. Debtors
2023 2022
£ £
Trade debtors 6,942 12,731
Other debtors 6,100 1,484
_______ _______
13,042 14,215
_______ _______
6. Creditors: amounts falling due within one year
2023 2022
£ £
Bank loans and overdrafts 12 -
Trade creditors 1,586 473,910
Corporation tax ( 459) -
Social security and other taxes 3,152 1,019
Other creditors 70,437 76,831
_______ _______
74,728 551,760
_______ _______
7. Directors advances, credits and guarantees
During the year the director entered into the following advances and credits with the company:
2023
Balance brought forward Advances /(credits) to the director Balance o/standing
£ £ £
R W Kenny 143 2,911 3,054
_______ _______ _______
2022
Balance brought forward Advances /(credits) to the director Balance o/standing
£ £ £
R W Kenny 143 - 143
_______ _______ _______